Award
NIH Reporter #3U19AG063911-07S4
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration, Cycle 2 (ALLFTD2)
Recipient
Mayo Clinic Rochester
Award Amount
$540,000.00
Ceiling
$540,000.00
Awarded
August 14, 2026
Identifier
3U19AG063911-07S4
NIH-funded project by Mayo Clinic Rochester to study Frontotemporal Lobar Degeneration, aiming to develop effective treatments through extensive data collection and participant enrollment.
Description
A comprehensive program on Frontotemporal Lobar Degeneration (FTLD), focusing on expanding infrastructure, data collection, and sharing to foster development of effective treatments. The project aims to enroll 1450 participants over 5 years, including individuals with familial and sporadic FTLD, and focuses on clinical, biofluid, and imaging data collection every 3-6 months.